1. |
Acetazolamide for preventing acute altitude sickness? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1270,
2001,
Page 2-2
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
2. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1270,
2001,
Page 3-3
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
3. |
Amiodarone for AF prevention means increased resource use |
|
Inpharma Weekly,
Volume &NA;,
Issue 1270,
2001,
Page 4-4
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
4. |
Etanercept - the low-cost route to relief in rheumatoid arthritis |
|
Inpharma Weekly,
Volume &NA;,
Issue 1270,
2001,
Page 5-6
Amanda Cameron,
Preview
|
|
摘要:
Rheumatoid arthritis (RA) - a chronic, debilitating disease with a progressive course - has important economic consequences. In The Netherlands, where the incidence of RA has been estimated at 1-1.5%, the new agent etanercept ['Enbrel'] has recently been granted reimbursement for use in patients with RA. The agent, a tumour necrosis factor (TNF) inhibitor, can be administered at home by SC injection. Research presented at the ISPOR*3rd Annual European Conference [Antwerp, Belgium; November 2000] demonstrates that etanercept's ease of administration translates into cost savings for Dutch society, compared with another TNF inhibitor, infliximab, which requires IV infusion in a hospital setting.
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
5. |
Tibolone: additional cost negligible in postmenopausal women |
|
Inpharma Weekly,
Volume &NA;,
Issue 1270,
2001,
Page 6-6
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
6. |
Gene therapy: potential in arrhythmias? |
|
Inpharma Weekly,
Volume &NA;,
Issue 1270,
2001,
Page 7-7
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
7. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1270,
2001,
Page 8-8
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
8. |
Nesiritide tops nitroglycerin in acute decompensated CHF |
|
Inpharma Weekly,
Volume &NA;,
Issue 1270,
2001,
Page 9-10
Amitabh Prakash,
Preview
|
|
摘要:
The results of a landmark study have shown that nesiritide, a recombinant form of B-type natriuretic peptide (BNP), improves the treatment of acute decompensated chronic heart failure (CHF). The VMAC*trial, presented at the 73rd Scientific Sessions of the American Heart Association [New Orleans, US; November 2000] showed that nesiritide ['Natrecor'] is significantly better than nitroglycerin [glyceryl trinitrate] and placebo in reducing pulmonary capillary wedge pressure (PCWP) in such patients. The drug was also significantly better than placebo in reducing dyspnoea. Scios, which manufactures the drug, will use the data to submit a New Drug Application amendment to the US FDA.
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
9. |
Intranasal estradiol comparable to transdermal estradiol |
|
Inpharma Weekly,
Volume &NA;,
Issue 1270,
2001,
Page 11-11
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|
10. |
News in brief ... |
|
Inpharma Weekly,
Volume &NA;,
Issue 1270,
2001,
Page 12-12
&NA;,
Preview
|
|
ISSN:1173-8324
出版商:ADIS
年代:2001
数据来源: ADIS
|